Real-world treatment patterns and clinical outcomes among patients with stage I-? non-small cell lung cancer in South Korea
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0006723
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 4000
Inclusion Criteria
•Aged = 18 years at the initial NSCLC diagnosis
•Patients who were diagnosed as NSCLC by histologic or cytologic confirmation from January 1, 2014 to December 31, 2017
•Patients who were diagnosed as Stage I, II and III resectable or unresectable NSCLC (according to Version 7 of the IASLC Staging)
Exclusion Criteria
•Patients who were diagnosed as small cell lung cancer
•Patients whose medical records are not available for review
•Patients who had not received any treatment (surgery, chemotherapy, radiotherapy, etc.) after diagnosis of stage I, II and III NSCLC
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the treatment patterns and real-world disease free survival (rwDFS) in the NSCLC patients with complete resection
- Secondary Outcome Measures
Name Time Method Real-world Progression-free survival (rwPFS), 3 years overall survival (OS), patient’s characteristics, treatment pattern ;Rate and clinical outcomes including recurrence rate and 3 years survival rate, real-world Progression-free survival (rwPFS) of adjuvant chemotherapy treatment after surgery ;Treatment pattern and real-world Progression-free survival (rwPFS) after recurrence ;o3 year overall survival(OS) in both resected and unresected population;Proportion and results of target gene (EGFR) mutation test ;The data of diagnostic evaluation and their results in stage I, II and III NSCLC;Analysis of patient’s characteristics, treatment in both resected and unresected population